Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1349243

registered interest
date	21/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the efficacy of covid-19 vaccines for recipients of solid organ transplants.
tabling member constituency	Lewisham, Deptford
tabling member printed	Vicky Foxcroft
uin	37534
answer	answer is ministerial correction date of answer 06/09/2021 answer text <p>Public Health England has been monitoring the effectiveness of vaccinations in clinical risk groups with immunosuppression, which includes recipients of solid organ transplants. From the evaluation of the vaccine programme, the data shows that completion of the two dose schedule correlates well with protection from both disease and severe outcomes, including hospitalisation and death.</p><p> </p><p>Virus Watch, supported by the UK Research and Innovation and National Institute for Health Research COVID-19 Rapid Response initiative and NHS Test and Trace, provided information regarding patients’ antibodies and included immunocompromised patients as part of their cohort. This suggests some protection against COVID-19 but is only one measure of protection and excludes cellular immunity.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 06/09/2021 11:24:59 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4491 label Biography information for Vicky Foxcroft

1347747

registered interest
date	16/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when his Department plans to offer people who are immunosuppressed, but not identified as extremely clinically vulnerable, a booster covid-19 vaccination as part of the covid-19 vaccination booster programme.
tabling member constituency	Lewisham, Deptford
tabling member printed	Vicky Foxcroft
uin	34548
answer	answer is ministerial correction date of answer 26/07/2021 answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI) published interim advice on a potential COVID-19 booster vaccination programme on 30 June, which is available at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/publications/uk-5-year-action-plan-for-antimicrobial-resistance-2019-to-2024%20" target="_blank">https://www.gov.uk/government/publications/uk-5-year-action-plan-for-antimicrobial-resistance-2019-to-2024 </a></p><p> </p><p>The JCVI advises a two staged approach, with individuals in stage one offered a booster and flu vaccine as soon as possible from September. Individuals in stage two should be offered a booster vaccine as soon as practicable after stage one, with equal emphasis on deployment of the flu vaccine where eligible. The JCVI suggests that adults aged 16 years old and over who are immunosuppressed are offered a booster vaccine in stage one.</p><p> </p><p>Final decisions on the timing and scope and cohort eligibility of any COVID-19 vaccine booster programme will be confirmed once the JCVI has provided their final advice.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 26/07/2021 16:15:40 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4491 label Biography information for Vicky Foxcroft

1339514

registered interest
date	23/06/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the effect of immunosuppressive medication on the effectiveness of covid-19 vaccinations; and whether those living with inflammatory immune-mediated conditions taking such medication should be advised to shield as a result.
tabling member constituency	Lewisham, Deptford
tabling member printed	Vicky Foxcroft
uin	21289
answer	answer is ministerial correction date of answer 29/06/2021 answer text <p>The Virus Watch study, supported by NHS Test and Trace, shows a modestly reduced antibody response after one COVID-19 vaccine dose among individuals with immunosuppression, including those on immunosuppressive therapy. However, this is not a direct measure of protection and it is still early to determine impact on clinical disease or whether the antibody response remains after a complete course of vaccination.</p><p> </p><p>Shielding was paused on 1 April 2021. Clinically extremely vulnerable people are advised to take the extra precautions provided by the Government to reduce their chance of infection and must continue to follow the current regulations.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 29/06/2021 15:24:13 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4491 label Biography information for Vicky Foxcroft

1305297

registered interest
date	23/03/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many and what proportion of (a) people with cystic fibrosis other respiratory conditions and (b) other clinically extremely vulnerable people in England have been vaccinated against covid-19.
tabling member constituency	Lewisham, Deptford
tabling member printed	Vicky Foxcroft
uin	174172
answer	answer is ministerial correction date of answer 09/04/2021 answer text <p>We do not hold data on vaccination totals by specific medical condition, such as cystic fibrosis or other respiratory conditions.</p><p>NHS England and NHS Improvement do provide a weekly breakdown of data on vaccinations administered to clinically extremely vulnerable people. This information is updated on Thursdays, and can be found at the following link:</p><p><a href="http://www.england.nhs.uk/statistics/statistical-work-areas/covid-19-vaccinations/" target="_blank">www.england.nhs.uk/statistics/statistical-work-areas/covid-19-vaccinations/</a></p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 09/04/2021 12:25:13 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4491 label Biography information for Vicky Foxcroft

1273079

registered interest
date	30/12/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Baby Care Units: Nurses
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the findings of the National Neonatal Audit Programme, published November 2020, that 37 per cent of neonatal intensive care unit shifts met the qualified in speciality (QIS) specification for neonatal nurses in 2019, how many QIS trained neonatal nurses have been redeployed to the covid-19 vaccine programme; and what steps he plans to take to support units to backfill those specialist roles while vaccine rollout is ongoing.
tabling member constituency	Lewisham, Deptford
tabling member printed	Vicky Foxcroft
uin	133067
answer	answer is ministerial correction date of answer 27/04/2021 answer text <p>Data on the number of qualified in specialty trained nurses redeployed to the COVID-19 vaccine programme is not held centrally. To avoid the need for specialist roles to be backfilled, NHS England and NHS Improvement set out the expectation that local units take into account safe staffing levels when releasing members of staff to assist in the vaccination programme.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 27/04/2021 10:33:22 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4491 label Biography information for Vicky Foxcroft

1258904

registered interest
date	07/12/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Baby Care Units: Coronavirus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether parents of babies in neonatal units will be given priority access to a covid-19 vaccination.
tabling member constituency	Lewisham, Deptford
tabling member printed	Vicky Foxcroft
uin	126073
answer	answer is ministerial correction date of answer 10/03/2021 answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI) consists of independent experts who advise the Government on which vaccine/s the United Kingdom should use and provide advice on prioritisation at a population level. They advised that phase one of the vaccination programme should have the prevention of mortality at the forefront of its objectives, as well as supporting the National Health Service and social care system.</p><p>Parents of babies in neonatal units who are aged over 50 years old or who have underlying health conditions which make them clinically vulnerable or clinically extremely vulnerable to COVID-19 are being given priority access to a COVID-19 vaccination in the first phase, which we are aiming to complete by the middle of April. All other parents of babies in neonatal units will be offered the vaccine in priority order, with a target date of the end of July, in line with advice from the JCVI.</p><p>The JCVI has recommended that access to the COVID-19 vaccines should continue to be prioritised by age as this is the biggest determining factor to increased mortality from the disease.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 10/03/2021 14:22:06 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4491 label Biography information for Vicky Foxcroft